Realtime | Geld | Brief | Zeit |
---|---|---|---|
2,685 | 2,845 | 23:01 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
10.04. | Nightingale Health Oyj: Nightingale Health's laboratory implementation in the United States progresses as planned - opens first to medical research customers in Summer 2025 | 96 | GlobeNewswire (Europe) | Nightingale Health Plc | Press Release | April 10, 2025 at 09:30:00 EEST
Nightingale Health Plc
Nightingale Health (Nasdaq Helsinki: HEALTH; OTCQX: NHLTY, NGHLF) a pioneer in disease risk detection... ► Artikel lesen | |
25.03. | Citi Appointed as Depositary Bank for Nightingale Health OYJ's ADR Program | 297 | Business Wire | Citi Issuer Services, acting through Citibank N.A., has been appointed by Nightingale Health OYJ ("Nightingale Health") to act as depositary bank for its sponsored Level 1 American Depositary Receipt... ► Artikel lesen | |
21.03. | Trading in Nightingale Health's B shares and ADRs begins on 21 March 2025 on the OTCQX International Market in the US | 1 | Cision News | ||
21.03. | OTC Markets Group Welcomes NIGHTINGALE HEALTH OYJ to OTCQX | 1 | GlobeNewswire (USA) | ||
19.03. | Nasdaq Helsinki welcomes Nightingale Health to Main Market | 148 | GlobeNewswire | 19 March 2025, Helsinki - Nasdaq (Nasdaq: NDAQ) announces that trading in Nightingale Health Plc shares (ticker: HEALTH) will commence today on the Main Market of Nasdaq Helsinki. Nightingale Health... ► Artikel lesen | |
NIGHTINGALE HEALTH Aktie jetzt für 0€ handeln | |||||
18.03. | Nightingale Health Plc's listing application has been approved and trading in its Series B shares on the Main Market of Nasdaq Helsinki will commence on 19 March 2025 | 1 | Cision News | ||
18.03. | Nightingale Health Plc: Move From Nasdaq First North Growth Market Finland To The Official List | 143 | GlobeNewswire | EXCHANGE NOTICE, 18 MARCH 2025 SHARES
NIGHTINGALE HEALTH PLC: MOVE FROM NASDAQ FIRST NORTH GROWTH MARKET FINLAND TO THE OFFICIAL LIST
At the request of Nightingale Health Plc, the... ► Artikel lesen | |
17.03. | The Finnish Financial Supervisory Authority has approved Nightingale Health Plc's Finnish prospectus | 1 | Cision News | ||
17.03. | Nightingale Health Oyj: Nightingale Health establishes ADR program in the US - trading in Company's B shares and ADRs begins on 19 March 2025, at the earliest, and 24 March 2025, at the latest, on the OTCQX Market in the ... | 99 | GlobeNewswire (Europe) | Nightingale Health Plc
Stock exchange release
17 March 2025 at 1:55 p.m. (EET)Nightingale Health Plc ("Nightingale Health" or the "Company") announced on 27 November 2024 that it was investigating... ► Artikel lesen | |
12.03. | Nightingale Health Plc applies for its series B shares to be listed on the Main Market of Nasdaq Helsinki | 3 | Cision News | ||
06.03. | Nightingale Health Oyj: Nightingale Health's half-year report: International expansion continues in Southeast Asia and the United States | 316 | GlobeNewswire (Europe) | Nightingale Health Group's Half-year report 1 July 2024 - 31 December 2024 (unaudited) Nightingale Health's half-year report: International expansion continues in Southeast Asia and the United States
Company... ► Artikel lesen | |
28.02. | Nightingale Health to publish half-year report for July - December 2024 on 6 March 2025 | 1 | Cision News | ||
27.02. | Nightingale Health announces the development of innovative LLM based tool to empower anyone to take informed decisions to lower disease risks | 2 | Cision News | ||
07.02. | Nightingale Health Oyj: Nightingale Health announces its updated regulatory plan in the United States | 168 | GlobeNewswire (Europe) | Nightingale Health Plc
Press release
7 February 2025 at 2:15 p.m. (EET)Nightingale Health Plc ("Nightingale Health"), a pioneer in disease risk detection and preventative health announces its regulatory... ► Artikel lesen | |
27.01. | Nightingale Health and Enigma Genomics enter into collaboration to sell the Nightingale Remote Health Check in the MENA region | 1 | Cision News | ||
23.01. | Nightingale Health announces the performance metrics of its latest generation disease risk assessments to be rolled out in Singapore and the United States | 1 | Cision News | ||
23.12.24 | Conversion of Nightingale Health Plc's EMP shares to Series B shares | 1 | Cision News | ||
20.12.24 | Nightingale Health Plc - Managers' Transactions - Olli Karhi | 1 | Cision News | ||
18.12.24 | Nightingale Health Plc appoints Lago Kapital as liquidity provider | 2 | Cision News | ||
13.12.24 | Nightingale Health Plc: Subscription of Series B shares with option rights | 2 | Cision News |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
INTUITIVE SURGICAL | 502,50 | -0,83 % | Intuitive Surgical Promotes President Dave Rosa As CEO | SUNNYVALE (dpa-AFX) - Intuitive Surgical, Inc. (ISRG), a biotechnology company, on Thursday announced the promotion of President Dave Rosa as Chief Executive Officer, effective from July 1.... ► Artikel lesen | |
RHOEN-KLINIKUM | 12,800 | +0,79 % | Stärkung ethischer Standards in Forschung und Patientenversorgung / RHÖN-KLINIKUM Campus Bad Neustadt gründet Ethik-Kommission | Bad Neustadt a.d. Saale (ots) - Die RHÖN-KLINIKUM AG hat am Campus Bad Neustadt eine Ethik-Kommission begründet. Das neue Gremium übernimmt seit März 2025 eine zentrale Rolle bei der Bewertung und Beratung... ► Artikel lesen | |
BICO GROUP | 3,188 | -7,00 % | Bico Group Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
M1 KLINIKEN | 14,800 | -0,80 % | M1 Kliniken mit kräftigem Ergebnisplus im Geschäftsjahr 2024 | Die M1 Kliniken AG hat im Geschäftsjahr 2024 Wachstum bei Umsatz und Ergebnis erzielt. Der Konzernumsatz erhöhte sich um 7 Prozent auf 339,2 Millionen Euro, nach 316,3 Millionen Euro im Vorjahr. Besonders... ► Artikel lesen | |
BAXTER | 27,655 | +1,88 % | Baxter-Aktie mit Kursgewinnen (28,4412 €) | Im Plus liegt gegenwärtig der Anteilsschein von Baxter . Die Aktie notiert derzeit bei 31,95 US-Dollar. Im US-amerikanischen Wertpapierhandel hat sich heute das Wertpapier von Baxter zwischenzeitlich... ► Artikel lesen | |
LIFEWARD | 1,315 | -8,68 % | Lifeward Ltd. Reports First Quarter 2025 Financial Results | U.S. pipeline of ReWalk opportunities continues to build with over 120 qualified leads in process Closure of AlterG sites and resulting consolidation of resources and reduced expenditures yields improved... ► Artikel lesen | |
JD HEALTH | 4,440 | -3,48 % | CCBI Lifts JD HEALTH's TP to HKD45.4; 1Q25 Rev. & GPM Beat | ||
COOPER COMPANIES | 72,00 | -0,69 % | CooperCompanies Updates FY25 Outlook | WASHINGTON (dpa-AFX) - While reporting its results for the first quarter on Thursday, medical devices company CooperCompanies (COO), updated its fiscal year 2025 financial guidance. For the... ► Artikel lesen | |
COMMUNITY HEALTH SYSTEMS | 3,740 | +6,25 % | COMMUNITY HEALTH SYSTEMS INC - 8-K, Current Report | ||
ONWARD MEDICAL | 4,280 | -0,23 % | ONWARD Medical NV: ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders and Proposed Resolutions | EINDHOVEN, the Netherlands, April 30, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX ONWRY), the medical technology company creating innovative spinal cord stimulation therapies... ► Artikel lesen | |
RAMSAY HEALTH CARE | 20,200 | -1,94 % | RAMSAY HEALTH CARE LIMITED: Ramsay Sante 3QFY25 Earnings Update | ||
SENSUS HEALTHCARE | 4,300 | -0,46 % | Sensus Healthcare GAAP EPS of -$0.16 misses by $0.19, revenue of $8.3M beats by $1.07M | ||
SONIDA SENIOR LIVING | 23,000 | -0,86 % | Sonida Senior Living outlines $100M NOI target amid portfolio repositioning and strategic acquisitions | ||
SAVARIA | 12,500 | 0,00 % | Dividendenbekanntmachungen (09.05.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AAK AB SE0011337708 5 SEK 0,4573 EUR ADDLIFE AB SE0014401378 0,75 SEK 0,0686 EUR ALLIANZ SE DE0008404005 - 15,4 EUR ALZCHEM GROUP... ► Artikel lesen | |
XVIVO PERFUSION | 30,140 | +1,96 % | XVIVO Perfusion AB: XVIVO Presents 12-Month Follow-Up Results from European Multicenter Heart Transplantation Trial at ISHLT in Boston | GOTHENBURG, SE / ACCESS Newswire / April 29, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - The 12-month follow-up results from XVIVO's European multicenter heart trial, NIHP2019, was presented... ► Artikel lesen |